Synthetic Cannabinoids: Illegal and Dangerous PDF Print E-mail
 BALTIMORE (August 28, 2012) – The Department of Health and Mental Hygiene (DHMH) advises Marylanders that a large number of Synthetic Cannabinoids, known by a variety of names such as “Spice” and “K2,” have been recently added to the federal list of Schedule 1 Controlled Substances. State and local health officials have long expressed concern about these products, which are marijuana-like synthetic compounds linked to potentially severe adverse reactions and abuse.
So far in 2012, the Maryland Poison Control has received 159 calls related to the use of Synthetic Cannabinoids, compared to a total of 151 calls in 2011.  More than half of the calls involved individuals age 19 or younger, and the calls have come from 20 of Maryland’s 24 counties.  Four involved admission to an Intensive Care Unit.

“Whether sold on the street or at a convenience store, synthetic cannabinoids pose a threat,” said Frances B. Phillips, Deputy Secretary for Public Health Services.  “This is another important topic for parents to discuss with their adolescents in order to protect their health.”

In January 2012, following a public comment period, the Department supported legislation to ban the sale of synthetic cannabinoids in Maryland. The recent federal action accomplishes this goal for Maryland and other states. 

Now that the sale of these products is illegal under federal law, the Department urges retailers to remove them from their shelves.

For more information: DEA: Nationwide Synthetic Drug Takedown
http://www.justice.gov/dea/pubs/pressrel/pr072612.html

FBI Law Enforcement Bulletin: Synthetic Marijuana 
http://www.fbi.gov/stats-services/publications/law-enforcement-bulletin/may-2012/synthetic-marijuana/
Last Updated on Tuesday, 28 August 2012 11:40
 
 

Substance Abuse Help

 

Zika Information

 

Rabies Information


     

WCHD News

Medicaid, HealthChoice MCOs take steps to prevent opioid-related problems. Response follows treatment reimbursement boost in program’s renewed waiver.

Baltimore, MD (February 8, 2017) – In keeping with the Hogan administration’s leadership in fighting the opioid crisis in Maryland, the Department of Health and Mental Hygiene is announcing policies reforming the opioid-prescribing process in the Medicaid program, to seek to block the prescription pathway to substance use disorders.
Read more...
 
Maryland urges testing on National Black HIV/AIDS Awareness Day. State utilizing 5-year plan for prevention, care services; builds on collaborations.
 
Baltimore, MD (February 6, 2017) – Tuesday is National Black HIV/AIDS Awareness Day (NBHAAD), and the Department of Health and Mental Hygiene’s Prevention and Health Promotion Administration is encouraging all Marylanders to support HIV education, prevention, testing and care.
Read more...
 
Md. health dept., ex-Raven Orr ‘team up’ for public service videos on opioids. Marylanders can find treatment resources at MdDestinationRecovery.org.
 
Baltimore, MD (February 6, 2017) – As part of the Hogan administration’s continued efforts to save lives and promote recovery amid the opioid crisis, the Department of Health and Mental Hygiene’s Behavioral Health Administration has released a series of public service announcements (PSAs) to be shown on TV and in movie theaters.
Read more...
 
 Lower Shore Health Insurance Assistance Program
Web Mastering by
 www.WheatleyComputers.com